Indeed, as reviewed elsewhere, several preclinical studies have hypothesized that inhibition of PCSK9 through genetic depletion, monoclonal antibodies, nano-liposomal vaccination, or siRNA might effectively suppress tumor growth [26]. The gene discussed is PCSK9; the disease is neoplasm.